Pharmacokinetics of Ceftriaxone
Overview
Authors
Affiliations
Ceftriaxone fulfills many of the qualities of an ideal antibiotic: a prolonged elimination half-life, which results from a "restrictive" excretion pattern; saturable protein binding, which provides the theoretical basis for administering the total daily dose as a single bolus; and once-a-day dosing, which provides plasma and tissue concentrations that exceed the MIC for most susceptible pathogens for 24 hours.
Wiesli M, Livio F, Achermann Y, Gautier E, Wahl P Bone Joint Res. 2022; 11(11):835-842.
PMID: 36384300 PMC: 9680198. DOI: 10.1302/2046-3758.1111.BJR-2022-0180.R1.
Safety of ceftriaxone in paediatrics: a systematic review protocol.
Zeng L, Choonara I, Zhang L, Xue S, Chen Z, He M BMJ Open. 2017; 7(8):e016273.
PMID: 28827252 PMC: 5634450. DOI: 10.1136/bmjopen-2017-016273.
Antibiotics and breast-feeding: a critical review of the literature.
Chung A, Reed M, Blumer J Paediatr Drugs. 2002; 4(12):817-37.
PMID: 12431134 DOI: 10.2165/00128072-200204120-00006.
Perry T, Schentag J Clin Pharmacokinet. 2001; 40(9):685-94.
PMID: 11605716 DOI: 10.2165/00003088-200140090-00004.
Brandt C, Warner C, Rouse M, Steckelberg J, Wilson W Antimicrob Agents Chemother. 1996; 40(12):2901-3.
PMID: 9124865 PMC: 163646. DOI: 10.1128/AAC.40.12.2901.